Dr. Steven P. Cohen added hydrodissection — injecting fluid around severed nerves — to typical opioid use in treating ...
A new Mount Sinai study provides compelling evidence that exercise can significantly help the mental well-being of millions ...
Doctors at NexGenEsis Healthcare say they are revolutionizing pain relief with regenerative medicine
Dr. Abhishek Reddy and Dr. Joe Fuhrman stop by Houston Life to discuss their innovative approach to pain management.
The use of powerful synthetic opioids, such as sufentanil and remifentanil, during surgery is linked to a subsequent poor ...
The one-size-fits-all approach to pain management should be a thing of the past. But we’re still not there yet.
“I believe JOURNAVX could redefine the management of pain and become a foundational treatment option for people with all types of moderate-to-severe acute pain, where options aside from opioids ...
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
On January 30, 2025, the US FDA approved Journavx (suzetrigine) 50mg oral tablets to use in the treatment of moderate to severe acute pain, making it the first non-opioid analgesic of its class to ...
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
Developing new painkilling treatments relies on the work of pain researchers to unravel the intricate neuronal circuitry and function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback